Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial.
作者信息
Leypoldt Lisa B, Besemer Britta, Asemissen Anne Marie, Hänel Mathias, Blau Igor Wolfgang, Görner Martin, Ko Yon-Dschun, Reinhardt Hans Christian, Staib Peter, Mann Christoph, Lutz Raphael, Munder Markus, Graeven Ullrich, Peceny Rudolf, Salwender Hans, Jauch Anna, Zago Manola, Benner Axel, Tichy Diana, Bokemeyer Carsten, Goldschmidt Hartmut, Weisel Katja C
机构信息
Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany.
出版信息
Leukemia. 2022 Mar;36(3):885-888. doi: 10.1038/s41375-021-01431-x. Epub 2021 Nov 3.
Abstract
摘要
Zotero 插件